PRF Technologies Ltd.
No SEC Form 4 filings for $PRFX in the last 30 days.
See all $PRFX insider activity →PRF Technologies (PRFX) reported $11M in cash, $2.5M in liabilities, and a $3.7M operating loss for the nine months ended September 30, 2026. The company raised $10.5M via equity line. Its subsidiary, LayerBio, plans a Phase 2 trial for OcuRing-K. PRFX also aims to spin off GridFeed, an AI-driven renewable energy platform, as a standalone subsidiary.
PRF Technologies (Nasdaq: PRFX) said it expanded its DeepSolar Predict AI platform with “Battery-to-Revenue Intelligence,” adding workflows to optimize battery energy storage revenue using state of charge, constraints, and market conditions. The update follows real-world European validation using market data and is part of progress toward a planned commercial launch and GridFeed trading platform.
PRF Technologies Ltd. (Nasdaq: PRFX) said its DeepSolar unit completed an initial validation of DeepSolar Predict, an AI revenue optimization platform for renewable energy. The validation used real-world European weather, production, and market data across day-ahead and intraday scenarios. The company said this supports its planned commercial launch.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning PRFX (PRF Technologies Ltd.). Coverage has been balanced: 0 bullish, 3 neutral, and 0 bearish.
Recent PRFX coverage spans financial news, technology and corporate actions.
Equity raise may dilute existing shareholders while providing cash for trial and GridFeed initiatives.
Product expansion and planned commercial rollout could improve perceived commercialization momentum for PRFX’s DeepSolar platform.
Validation progress supports the planned commercial launch timeline for DeepSolar Predict, but the release provides no revenue, contract, or launch date.
Commercial-launch advancement of DeepSolar Predict is a potential catalyst for PRFX’s AI-energy software narrative and future revenue expectations.
PRF Technologies Ltd. has filed an SEC Form EFFECT, indicating the notice of effectiveness for its F-1 registration statement. The filing's effectiveness on May 19, 2026, suggests the company is progressing with its capital raising or public offering plans, which could influence investor sentiment and stock liquidity.
AlphAI scores every news story that mentions PRFX with an AI model for sentiment and relevance, and aggregates insider trades from PRF Technologies Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
PRF Technologies (PRFX) reported $11M in cash, $2.5M in liabilities, and a $3.7M operating loss for the nine months ended September 30, 2026. The company raised $10.5M via equity line. Its subsidiary, LayerBio, plans a Phase 2 trial for OcuRing-K. PRFX also aims to spin off GridFeed, an AI-driven renewable energy platform, as a standalone subsidiary.
2 min readPRF Technologies (Nasdaq: PRFX) said it expanded its DeepSolar Predict AI platform with “Battery-to-Revenue Intelligence,” adding workflows to optimize battery energy storage revenue using state of charge, constraints, and market conditions. The update follows real-world European validation using market data and is part of progress toward a planned commercial launch and GridFeed trading platform.
3 min readPRF Technologies Ltd. (Nasdaq: PRFX) said its DeepSolar unit completed an initial validation of DeepSolar Predict, an AI revenue optimization platform for renewable energy. The validation used real-world European weather, production, and market data across day-ahead and intraday scenarios. The company said this supports its planned commercial launch.
3 min readPRF Technologies (Nasdaq: PRFX) said it is advancing DeepSolar Predict, an AI platform aimed at commercial launch to optimize renewable energy revenue. The company says the system combines localized weather forecasting, production forecasting, imbalance risk management, and storage/portfolio optimization with real-time market decision support, building on its NVIDIA Connect participation and a previously filed weather-modeling patent.
3 min readPRF Technologies Ltd. (NASDAQ: PRFX) has announced an SEC filing of Form EFFECT, indicating a notice of effectiveness for its F-1 filing. The effectiveness date was May 19, 2026, at 4:30 P.M. The filing impact and sentiment are neutral, and the company has a market cap of $1.29 million.
2 min readPRF Technologies has received FDA IND clearance for OcuRing-K, a sustained-release ketorolac ring, allowing it to proceed to a U.S. Phase II clinical trial for post-cataract pain and inflammation. This development, leveraging LayerBio's ocular platform, aims to simplify recovery and improve adherence for cataract surgery patients. The company plans to launch the multi-center trial with patient enrollment targeted for the second half of 2026, advancing its ophthalmic strategy alongside its DeepSolar energy platform.
2 min readTEL AVIV, Israel, Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. ( Nasdaq: PRFX ) , a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six ...
3 min readTEL AVIV, Israel, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. PRFX, today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio, Inc., a privately held Boston-based biotechnology company advancing sustained-release drug delivery ...
4 min readTEL AVIV, Israel, July 10, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. PRFX, today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate ...
2 min read
